1-5 of 5
Bin Peng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy

Byung-Sik Cho, Zhihong Zeng, Hong Mu, Zhiqiang Wang, Sergej Konoplev, Teresa McQueen, Marina Protopopova, Jorge Cortes, Joseph R. Marszalek, Sheng-Bin Peng, Wencai Ma, R. Eric Davis, Donald E. Thornton, Michael Andreeff, Marina Konopleva
Journal: Blood
Blood (2015) 126 (2): 222–232.
https://doi.org/10.1182/blood-2015-02-628677
Published: 2015
Includes: Supplemental data
Journal Articles

Pronounced Anti-Leukemia Activity in Vivo of the Novel Peptidic CXCR4 Antagonist LY2510924 As a Single Agent and in Combination with Chemotherapy

Byung-Sik Cho, Zhihong Zeng, MD, Hong Mu, MD PhD, Zhiqiang Wang, Teresa McQueen, BS, Marina Protopopova, Jorge E. Cortes, MD, Joe Marszalek, Sheng-Bin Peng, Richard Eric Davis, Donald Thornton, MD, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3745.
https://doi.org/10.1182/blood.V124.21.3745.3745
Published: 2014
Journal Articles

A Phase I Study To Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of an Oral Platelet Growth Factor (SB-559448) in Healthy Subjects.

Sheng-Fang Su, PhD, Bin Peng, MD, PhD, Daphne Williams, Jung Wook Park, Malcolm L. Handel, BSc, MB BS, PhD, Julian Jenkins, MS, Peter Ho, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1072.
https://doi.org/10.1182/blood.V108.11.1072.1072
Published: 2006
Journal Articles

A Phase I/II Study of Intravenous LBH589, a Novel Histone Deacetylase (HDAC) Inhibitor, in Patients (pts) with Advanced Hematologic Malignancies.

Francis J. Giles, MD, Thomas Fischer, MD, Jorge Cortes, MD, James Beck, MD, Farhad Ravandi-Kashani, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Bin Peng, PhD, Patricia E. Rae, BSc, Glen Laird, Samil Sharma, MD, Margaret Dugan, MD, Maher Albitar, MD, Kapil M. Bhalla, MD
Journal: Blood
Blood (2004) 104 (11): 1802.
https://doi.org/10.1182/blood.V104.11.1802.1802
Published: 2004
Journal Articles

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study

Clinical Trials & Observations
Martin A. Champagne, Renaud Capdeville, Mark Krailo, Wenchun Qu, Bin Peng, Marianne Rosamilia, Martine Therrien, Ulrike Zoellner, Susan M. Blaney, Mark Bernstein
Journal: Blood
Blood (2004) 104 (9): 2655–2660.
https://doi.org/10.1182/blood-2003-09-3032
Published: 2004